Histopathological invasion patterns and prognosis in Oral Squamous Cell Carcinoma: A retrospective analysis of 560 cases.

Oral Oncol

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Oral and Maxillofacial Surgery, Berlin, Germany.

Published: March 2025

Background: Oral Squamous Cell Carcinoma (OSCC) remains a global health issue. Accurate histopathological assessment is vital for improving treatment outcomes. This study explores the impact of perineural, lymphatic, and vascular infiltration (Pn1, L1, V1) on OSCC progression, survival, and recurrence.

Methods: This retrospective study included 560 patients with primary OSCC who underwent curative surgical resection between 2012 and 2023. Data analyzed included demographics, tumor staging, histopathological features, treatment, and follow-up outcomes.

Results: A total of 322 males and 238 females with a mean age of 63.8 years were included. L1 was observed in 40 cases (7.1 %), Pn1 in 53 cases (9.5 %), and V1 in 4 cases (0.7 %). The mean follow-up was 29.7 months, with 3-y ear Overall Survival (OS) at 75.2 % and Recurrence-Free Survival (RFS) at 66.0 %. Multivariate logistic regression showed that contralateral lymph node metastases (CLNM) and ExtraCapsular Extension (ECE) were linked to L1 (OR: 7.83, OR: 2.52), while advanced disease and distant metastasis were strongly associated with Pn1 (OR: 12.70, OR: 6.27). Cox regression analysis revealed CLNM, ECE, and L1 were associated with reduced OS (HR: 2.32, HR: 1.82, HR: 1.90), and CLNM, ECE, L1, and poor differentiation (G3) were associated with reduced RFS (HR: 1.84, HR: 1.80, HR: 2.51, HR: 1.75). CLNM and Pn1 were strong predictors of reduced Distant Metastasis-Free Survival (DMFS).

Conclusion: L1 and Pn1 were associated with worse prognoses in OSCC, affecting OS, RFS, and DMFS. Research is required to clarify their roles, and including these factors in OSCC staging may improve treatment outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2025.107247DOI Listing

Publication Analysis

Top Keywords

oral squamous
8
squamous cell
8
cell carcinoma
8
treatment outcomes
8
clnm ece
8
associated reduced
8
oscc
5
pn1
5
histopathological invasion
4
invasion patterns
4

Similar Publications

TTP as Tumor Suppressor and Inflammatory Regulator in Oral Carcinogenesis.

J Dent Res

March 2025

Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE-UBA-CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.

The stability of messenger RNA (mRNA) is controlled by proteins that bind to adenosine-uridine-rich sequences (AREs) in their 3' untranslated regions (3'UTR), known as AU-binding proteins. One of these proteins is tristetraprolin (TTP; encoded by ), which promotes degradation of mRNAs with AREs in their 3'UTR. TTP accelerates the decay of its target transcripts, many of which encode proinflammatory mediators that promote tumorigenesis.

View Article and Find Full Text PDF

Characterization of Salivary Microbiota in Japanese Patients with Oral Cancer.

Int J Mol Sci

March 2025

Department of Oral and Maxillofacial Surgery, School of Dental Medicine, Tsurumi University, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama 230-8501, Japan.

This study aimed to characterize salivary microbiota in patients with oral cancer using 16S rRNA amplicon sequencing. DNA was extracted from saliva samples of 23 patients with oral cancer and 95 age-matched controls. A metagenomic analysis was performed using 16S rRNA amplicon sequencing.

View Article and Find Full Text PDF

Head and neck cancers (HNCs) are often diagnosed late, leading to poor prognosis. Chronic inflammation, particularly periodontitis, has been linked to carcinogenesis, but systemic inflammatory markers remain underexplored. This study was the first to examine whether elevated C-reactive protein (CRP) can serve as a cost-effective adjunct in HNC risk assessment, alongside oral health indicators.

View Article and Find Full Text PDF

Dinaciclib, a potent cyclin-dependent kinase (CDK) inhibitor, has demonstrated considerable antitumor effects in various malignancies. However, its impact on oral squamous cell carcinoma (OSCC), a predominant and highly aggressive form of head and neck squamous cell carcinoma (HNSC) with limited treatment options, remains underexplored. We conducted gene set enrichment analyses in HNSC patients that reinforced the relevance of these cell cycle-related genes to OSCC pathogenesis.

View Article and Find Full Text PDF

Head and Neck Squamous Cell Carcinoma (HNSCC) is a heterogeneous group of malignancies with poor survival outcomes, particularly in advanced stages. Identifying prognostic biomarkers could help improve patient management. miR-375, a small non-coding RNA, has been shown to influence tumor growth and immune responses, making it a candidate biomarker.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!